Typeone’s Post-Market Clinical Follow-Up Survey by Healthcare User Questionnaire (2024, 1.912 patients)
This post-market clinical follow-up survey evaluates the performance of a medical device through user feedback.
Ongoing Clinical Studies
Evaluating the Efficacy and Safety of Heterologous Type I Collagen (HTIC) in Age-Related Skin Atrophy: A Comprehensive Clinical Study (2024, 183 patients)
ongoing study.
Efficacy of Heterologous Type I Collagen Injections in Treating Atrophic Acne Scars: A Prospective Study (2024, 30 patients)
This prospective study assesses the effectiveness of HTIC injections for atrophic acne scars.
The promotional information regarding medical devices, in vitro diagnostic medical devices, and surgical medical supplies contained in this section is intended exclusively for healthcare professionals. Public access to promotional content is not permitted; any advertising messages are disseminated in compliance with the New Guidelines of the Italian Ministry of Health on Healthcare Advertising (published on July 21, 2025). By proceeding, you declare that you are a healthcare professional.